Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio
August 28th, 2018
Targeted genome editing in the model system Danio rerio (zebrafish) has been greatly facilitated by the emergence of CRISPR-based approaches. Herein, we describe a streamlined, robust protocol for generation and identification of CRISPR-derived nonsense alleles that incorporates the heteroduplex mobility assay and identification of mutations using next-generation sequencing.
Overview
This article presents a streamlined protocol for targeted genome editing in zebrafish using CRISPR/Cas9 technology. It emphasizes the generation and identification of CRISPR-derived nonsense alleles through a combination of techniques including the heteroduplex mobility assay and next-generation sequencing.
Key Study Components
Area of Science
- Genetics
- Developmental Biology
- Model Organisms
Background
- Zebrafish serve as an important vertebrate model for studying gene function.
- CRISPR/Cas9 technology allows for precise genome editing.
- Understanding gene roles can elucidate developmental processes in higher eukaryotes.
- This method is accessible to researchers at all experience levels.
Purpose of Study
- To provide a robust protocol for generating gene knockouts in zebrafish.
- To facilitate the identification of mutations resulting from CRISPR editing.
- To enable researchers to explore gene functions in developmental biology.
Methods Used
- Preparation of Cas9 protein and sgRNA for microinjection.
- Microinjection of zebrafish embryos with CRISPR components.
- Use of next-generation sequencing to identify mutations.
- Heteroduplex mobility assay for mutation analysis.
Main Results
- Successful generation of CRISPR-derived nonsense alleles in zebrafish.
- High survival rates of injected embryos post-microinjection.
- Effective identification of genomic modifications using sequencing techniques.
- Demonstration of the method's applicability for researchers of varying experience.
Conclusions
- The protocol provides a reliable approach for targeted genome editing in zebrafish.
- It enhances the ability to study gene functions in a vertebrate model.
- This method can be easily adopted by researchers and students alike.
Frequently Asked Questions
Executive Industry Relevance
This protocol enables rapid, cost-effective generation of gene knockouts in zebrafish, a key vertebrate model for target validation and phenotypic screening in early drug discovery. By providing a streamlined workflow for CRISPR-based genome editing accessible to researchers of all experience levels, it supports mechanistic de-risking and predictive confidence in therapeutic hypothesis testing. The method reduces resource requirements while maintaining high germline transmission efficiency, aligning with enterprise goals for scalable, reproducible discovery biology.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of gene function through protein-null allele generation in a vertebrate system.
- Operational Value: Supports rapid target validation using zebrafish embryos with high survival rates post-microinjection.
- Predictive Value: Facilitates biological de-risking by linking genotype to phenotype in a disease-relevant model.
Screening & Assay Development
- Scientific Value: Generates modified alleles suitable for downstream phenotypic and functional screening assays.
- Operational Value: Employs heteroduplex mobility assay (HMA) and NGS for standardized, quantitative indel detection.
- Scalability: Designed to minimize fish and equipment needs, enabling high-throughput allele identification.
Translational & Preclinical Research
- Translational Continuity: Uses zebrafish as a disease-relevant system to bridge discovery and preclinical validation.
- Mechanistic De-risking: Confirms germline transmission of CRISPR modifications, supporting F1 generation for inheritance studies.
- Predictive Confidence: Enables characterization of indels via NGS to predict functional impact of genetic perturbations.
Pipeline & Workflow Integration
The method integrates into early discovery workflows, supporting progression from target hypothesis to lead identification through reliable genome editing in zebrafish.
- Discovery Biology: Enables hypothesis testing via targeted gene knockout in a vertebrate model with high editing efficiency.
- Screening: Produces validated biological systems for assay development using HMA-confirmed founder fish.
- Analytics: Provides quantitative mutation analysis through HMA band intensity comparison and NGS-based indel sequencing.
- Translational Research: Supports continuity from gene editing to phenotypic assessment in developing zebrafish embryos.
- Enterprise Reuse: Optimized for low cost and undergraduate accessibility, enabling broad laboratory adoption and reagent sharing.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through precise, CRISPR-generated nonsense alleles.
- Operational Value: Standardization and reproducibility via streamlined sgRNA preparation and microinjection protocols.
- Strategic Value: Reduced late-stage biological risk through early functional gene interrogation in a vertebrate system.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on germline transmission and phenotypic outcomes.
Implementation Considerations
- Requires expertise in molecular cloning, embryo handling, and nucleic acid extraction techniques.
- Dependent on access to microinjectors, thermocyclers, gel electrophoresis, and spectrophotometry for QC.
- Necessitates standardization of sgRNA design and Cas9-sgRNA ribonucleoprotein complex formation across users.
- Adaptation considerations include varying sgRNA efficiency and potential mosaicism in injected embryos.
- Practical limitations include the need for phenotypic screening to distinguish functional knockouts from silent indels.
Biopharma FAQs
Chapters in this video
0:05
Title
1:09
Preparation of CRISPR-reagents for Embryo Microinjection
4:03
Microinjection of CRISPR-components into Zebrafish Embryos
6:12
Analysis of Efficiency of Indel Formation Using an HMA
8:45
Identification and Propagation of Knock-out Lines
9:45
Results: Zebrafish Embryos Exhibit a Pigment Defect when Injected with an sgRNA Targeting Tyrosinase at the One Cell Stage
10:32
Conclusion
